Pharmacophore modeling and 3D quantitative structure-activity relationship analysis of febrifugine analogues as potent antimalarial agent

Journal of Advanced Pharmaceutical Technology and Research

Volumn 4, Issue 1, 2013, Pages 50-60

  Sen, Debanjan ^a   Chatterjee, Tapan Kumar ^b  

^a SPLPIM Campus   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

3D QSAR; Antimalarial; febrifugine; pharmacophore; PHASE

Indexed keywords

ANTIMALARIAL AGENT; ANTISPOROZOAL AGENT; FEBRIFUGINE; FEBRIFUGINE DERIVATIVE; ISOFEBRIFUGINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG RESEARCH; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR MODEL; PHARMACOPHORE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS;

EID: 84881193210     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/2231-4040.107501     Document Type: Article

References (26)

1. Kuehl FA Jr, Spencer CF, Folkers K. Alkaloids of Dichroa Febrifuga Lour. J Am Chem Soc 1948;70:2091-3.
2. Koepfli JB, Mead JF, Brockman JA Jr. Alkaloids of Dichroa febrifuga. Isolation and Degradative Studies. J Am Chem Soc 1949;71:1048-54.
3. Murata K, Takano F, Fushiya S, Oshima Y. Enhancement of NO Production in Activated Macrophages in Vivo by an Antimalarial Crude Drug, Dichroa febrifuga. J Nat Prod 1998;61:729-33. (Pubitemid 28317132)
4. Harayama T, Takeuchi. Synthesis of febrifugine derivatives and a solution to the puzzle of the structural determination of febrifugine. Tetrahedron 2003;59:1639-46. (Pubitemid 36207540)
5. Redginal I, Hewitt IR, Wallace WS, Gill ER, Williams JH. An Antimalarial alkaloid from hydrangea: XIII. The effects of various synthetic quinazolones against plasmodium lophurae in ducks. Am J Trop Med Hyg 1952;1:768-77.
6. Fishman M, Cruickshank PA. Febrifugine antimalarial agents. Pyridine analogs of febrifugine. J Med Chem 1970;13:155-6.
7. Chien PL, Cheng CC. Structural modification of febrifugine. Some methylenedioxy analogs. J Med Chem 1970;13:867-70.
8. Kikuchi H, Tasaka H, Hirai S, Takaya Y, Iwabuchi Y, Ooi H, et al. Potent febrifugine analogues against the Plasmodium malaria Parasite. J Med Chem 2002;45:2563-70. (Pubitemid 34595226)
9. Takaya Y, Tasaka H, Chiba T, Uwai K, Tanitsu M, Kim HS, et al. New type of Febrifugine Analogus, Bearing a Quinolizidine Moiety, Show Potent Antimalarial Activity against palasmodium malaria parasite. J Med Chem 1999;42:3163-6. (Pubitemid 29384052)
10. Hirai S, Kikuchi H, Tasaka HS, Begum K, Wataya Y, Tasaka H, et al. Metabolite of febrifugine and its synthetic analogue by mouse liver S9 and their antimalarial activity against plasmodium malaria parasite. J Med Chem 2003;46:4351-9. (Pubitemid 37153015)
11. Dei-Cas E, Slomianny C, Charet P, Prensier G, Ajana F, Ramage C, et al. In vitro growth and chloroquine sensitivity of Plasmodium falciparum (FCR-3 strain) in red blood cells containing HbC. Parasitol Res 1987;73:306-12.
12. Chen IJ, Foloppe N. Drug-like Bioactive structures and conformational coverage with the LigPrep/ConfGen Suite: Comparison to programs MOE and catalyst. J Chem Inf Model 2010;50:822-39.
13. Yazal JE, Prendergast FG, Shaw DE, Pang YP. Protonation states of the chromophore of denatured green fluorescent proteins predicted by ab initio calculations. J Am Chem Soc 2000;122:11411-5.
14. Schneebeli ST, Hall ML, Breslow R, Friesner R. Quantitative DFT modeling of the enantiomeric excess for dioxirane-catalyzed epoxidations. J Am Chem Soc 2009;131:3965-73.
15. Mehdipour AR, Safarpour MA, Taghavi F, Jamali M. Density functional theory-based Quantitative Structure Activity Relationship (QSAR) study of alkanol and alkanthiol derivatives. QSAR Combi Sci 2009;28:568-75.
16. Deeb O, Clare BW. Comparison of AM1 and B3LYP-DFT for Inhibition of MAO-A by Phenylisopropylamines: A QSAR Study. Chem Biol Drug Des 2008;71:352-62. (Pubitemid 351347794)
17. Dixon SL, Smondyrev AM, Rao SN. PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des 2006;67:370-2.
18. Evans AA, Doman TN, Thorner DA, Bodkin MJ. 3D QSAR methods: Phase and catalyst compared. J Chem Inf Model 2007;47:1248-57. (Pubitemid 46973738)
19. Narkhede SS, Degani MS. Pharmacophore Refinement and 3D-QSAR Studies of Histamine H3 Antagonists. QSAR Comb Sci 2007;26:744-53. (Pubitemid 46984720)
20. Watts KS, Dalal P, Murphy RB, Sherman W, Friesner RA, Shelley JC. Conf gen: A conformational search method for efficient generation of bioactive conformers. J Chem Inf Model 2010;50:534-46.
21. Tawari NR, Bag S, Degani MS. Pharmacophore mapping of a series of pyrrolopyrimidines, indolopyrimidines and their congeners as multidrug resistance-associated protein (MRP1) modulators. J Mol Model 2008;14:911-21.
22. Gmiz-Hernndez AP, Artur S. Galstyan, Knapp EW. Understanding Rubredoxin redox potentials: Role of H-bonds on model complexes. J Chem Theory Comput 2009;5:2898-908.
23. Wold S, Geladi P, Esbensen K, Öhman J. Multi-way principal components-and PLS-analysis. J Chemom 1987;1:41-56.
24. Li Y, Wang Y, Zhang F. Pharmacophore modeling and 3D-QSAR
25. analysis of phosphoinositide 3-kinase p110a inhibitors. J Mol
26. Model 2010;16:1449-60.